Pathological complete response after neoadjuvant cyclin-dependent kinase 4/6 inhibitor and neoadjuvant endocrine therapy in locally advanced hormone receptor-positive breast cancer. Indian Journal of Case Reports, [S. l.], v. 10, n. 10, p. 322–324, 2024. DOI: 10.32677/ijcr.v10i10.4727. Disponível em: https://mansapublishers.com/index.php/ijcr/article/view/4727.. Acesso em: 22 nov. 2024.